Enrolling by invitationPhase 2NCT02646839
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Michael Pulsipher
- Principal Investigator
- Michael Pulsipher, MDChildren's Hospital Los Angeles
- Intervention
- CliniMacs TCR alpha-beta-Biotin system(device)
- Enrollment
- 50 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2015 – 2025
Study locations (11)
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Children's Hospital Oakland, Oakland, California, United States
- Stanford University Medical Center, Palo Alto, California, United States
- Rady Children's Hospital, San Diego, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Lurie Children's Hospital, Chicago, Illinois, United States
- New York Medical Center, Valhalla, New York, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Vanderbilt University - Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, United States
- University of Utah, Primary Children's Hospital, Salt Lake City, Utah, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Collaborators
University of California, San Francisco · Children's Hospital of Philadelphia · Medical College of Wisconsin · Ann & Robert H Lurie Children's Hospital of Chicago · New York Medical College · UCSF Benioff Children's Hospital Oakland · Vanderbilt University · Rady Children's Hospital, San Diego
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02646839 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07201974Virtual Reality for Post-Stroke Gait RehabilitationMcGill University
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University